多发性骨髓瘤的治疗

Therapy of multiple myeloma

异基因造血干细胞移植是惟一有可能治愈多发性骨髓瘤的方法，但其治疗相关死亡率高限制了其应用。自体造血干细胞移植对提高患者的生活质量及延长生存期起到了巨大的作用，近年来各种新药及传统的化疗方案加新药所组成的新的化疗方案的应用更进一步提高了自体造血干细胞移植的疗效。

Allogeneic hematopoietic stem cell transplantation is the only measure which can cure multiple myeloma, but the high mortality rate related with it limited its use. Autologous hematopoietic stem cell transplantation（Auto-HSCT） has made a great contribution at improving the patients＇ quality of life and prolonging the survival. In recent years, the application of new drugs and new chemotherapy regimen consisted of traditional chemotherapy and new drugs further enhance the curative effect.